July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Arndt Vogel: Study on Pembrolizumab and ctDNA in dMMR/MSI-H Tumors
May 20, 2025, 13:36

Arndt Vogel: Study on Pembrolizumab and ctDNA in dMMR/MSI-H Tumors

Arndt Vogel, Managing Senior Consultant and a Professor in the Department of Gastroenterology, Hepatology, and Endocrinology at Hannover Medical School, shared an article on X:

“Long-Term Efficacy of Pembrolizumab and the Clinical Utility of ctDNA in Locally Advanced dMMR/MSI-H Solid Tumors.

Undetectable ctDNA after pembrolizumab were more likely to have pCR and higher 2-year EFS rate. ctDNA helpful for decision making.”
Arndt Vogel: Study on Pembrolizumab and ctDNA in dMMR/MSI-H Tumors

Long-Term Efficacy of Pembrolizumab and the Clinical Utility of ctDNA in Locally Advanced dMMR/MSI-H Solid Tumors.

Authors: Michael LaPelusa, Wei Qiao, Bryan Iorgulescu, Francis San Lucas, Keyur Patel, Deepak Bhamidipati, Jane Varkey Thomas, Nancy You, Wai Chin Foo, Dipen Maru, Selvi Thirumurthi, Van Morris, Scott Kopetz, Michael Overman, and Kaysia Ludford.

You can read the full article on Journal of Nature Communications.

Arndt Vogel: Study on Pembrolizumab and ctDNA in dMMR/MSI-H Tumors

More posts featuring Arndt Vogel.